We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+7.16%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$7.42B
AUM Growth
+$1.24B
(+20%)
Cap. Flow
+$985M
Cap. Flow
% of AUM
13.27%
Top 10 Holdings %
Top 10 Hldgs %
10.68%
Holding
3,037
New
854
Increased
791
Reduced
777
Closed
600
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$49.3M |
| 2 |
Intuit
INTU
|
+$48.7M |
| 3 |
Costco
COST
|
+$47.9M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$47.4M |
| 5 |
Vanguard Real Estate ETF
VNQ
|
+$45.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$41M |
| 2 |
Dollar General
DG
|
+$39M |
| 3 |
Biogen
BIIB
|
+$36.8M |
| 4 |
iShares US Real Estate ETF
IYR
|
+$29.8M |
| 5 |
Waste Management
WM
|
+$29.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.19% |
| 2 | Consumer Discretionary | 16.12% |
| 3 | Healthcare | 11.21% |
| 4 | Financials | 10.17% |
| 5 | Industrials | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BBBY
2501
Bed Bath & Beyond
BBBY
$473M
| – | – |
-7,907
| Closed | -$204K |
|
2502
Cass Information Systems
CASS
$698M
| – | – |
-9,548
| Closed | -$373K |
|
2503
CBRE Group
CBRE
$40.8B
| – | – |
-37,557
| Closed | -$1.7M |
|
2504
Chemours
CC
$2.59B
| – | – |
-84,886
| Closed | -$1.3M |
|
2505
Cibus
CBUS
$130M
| – | – |
-287
| Closed | -$71K |
|
2506
Crown Castle
CCI
$32.7B
| – | – |
-6,654
| Closed | -$1.11M |
|
2507
Crown Holdings
CCK
$12.8B
| – | – |
-15,619
| Closed | -$1.02M |
|
2508
Cadiz
CDZI
$266M
| – | – |
-12,400
| Closed | -$126K |
|
2509
Celanese
CE
$5.09B
| – | – |
-72,436
| Closed | -$6.25M |
|
2510
Chegg
CHGG
$108M
| – | – |
-106,697
| Closed | -$7.18M |
|
2511
Coherus Oncology
CHRS
$217M
| – | – |
-16,280
| Closed | -$291K |
|
2512
Grupo Cibest SA
CIB
$20.4B
| – | – |
-11,047
| Closed | -$291K |
|
2513
Colgate-Palmolive
CL
$72.6B
| – | – |
-55,825
| Closed | -$4.09M |
|
2514
Clarus
CLAR
$125M
| – | – |
-16,279
| Closed | -$188K |
|
2515
Clarivate
CLVT
$1.3B
| – | – |
-20,470
| Closed | -$457K |
|
|
CMA
2516
DELISTED
Comerica
CMA
| – | – |
-41,297
| Closed | -$1.57M |
|
2517
Commercial Metals
CMC
$7.63B
| – | – |
-31,360
| Closed | -$640K |
|
2518
Compass Minerals
CMP
$1.24B
| – | – |
-29,720
| Closed | -$1.45M |
|
2519
Cannae Holdings
CNNE
$647M
| – | – |
-40,476
| Closed | -$1.66M |
|
2520
Center Bancorp
CNOB
$1.63B
| – | – |
-10,867
| Closed | -$175K |
|
2521
CenterPoint Energy
CNP
$29.1B
| – | – |
-104,374
| Closed | -$1.95M |
|
2522
Cocrystal Pharma
COCP
$12.4M
| – | – |
-859
| Closed | -$16K |
|
2523
Capital One
COF
$124B
| – | – |
-134,883
| Closed | -$8.44M |
|
2524
Coherent
COHR
$55.2B
| – | – |
-29,807
| Closed | -$1.41M |
|
2525
Cohu
COHU
$2.39B
| – | – |
-20,352
| Closed | -$353K |
|
Similar funds
Squarepoint's Q3 2020 Portfolio in Review
As of Q3 2020, Squarepoint held 3,037 positions worth $7.42B, up 20% from $6.18B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Squarepoint deployed $985M of net new capital in Q3 2020, opening 854 new positions and adding to 791 existing holdings. Its largest new stake was Salesforce: 186,017 shares worth $46.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Pfizer, an estimated $41M trimmed.
- Squarepoint's largest Q3 2020 buy was Salesforce: 186,017 shares worth $46.8M.
- Squarepoint added most to Visa in Q3 2020, an estimated $49.3M increase.
- Squarepoint's biggest Q3 2020 reduction was Pfizer, cutting an estimated $41M.
- Squarepoint fully exited Biogen in Q3 2020, selling an estimated $36.8M.
- Squarepoint's ten largest holdings make up 11% of its $7.42B portfolio in Q3 2020.
- Squarepoint opened 854 new positions and closed 600 in Q3 2020.
- Squarepoint's portfolio value rose 20% quarter-over-quarter to $7.42B.
Based on Squarepoint's 13F filing for Q3 2020, filed 16 Nov 2020.